Network-based identification and prioritization of key regulators of coronary artery disease loci

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 36, Issue 5, 2016, Pages 928-941

  Zhao, Yuqi ^a   Chen, Jing ^b   Freudenberg, Johannes M ^b   Meng, Qingying ^a   Rajpal, Deepak K ^b   Yang, Xia ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

coronary artery disease; gene expression; gene regulatory networks; genome wide association study; genomics

Indexed keywords

LIPID; LUM PROTEIN, HUMAN; LUMICAN; STAT3 PROTEIN; STAT3 PROTEIN, HUMAN;

ANXA3 GENE; ARTICLE; CCL18 GENE; COL1A1 GENE; COL4A2 GENE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CXCL10 GENE; CXCL12 GENE; DRUG INFORMATION; DRUG TARGETING; DUSP1 GENE; DUSP6 GENE; EXTRACELLULAR MATRIX; F2 GENE; GBP1 GENE; GBP2 GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENE INTERACTION; GENE REGULATORY NETWORK; GENETIC ASSOCIATION; GENOME; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HGD GENE; HUMAN; IMMUNITY; INFLAMMATION; LIPID METABOLISM; LOXL2 GENE; LUM GENE; MOLECULAR PATHOLOGY; MSN GENE; MTMR11 GENE; PRIORITY JOURNAL; REGULATOR GENE; SHC1 GENE; SIGNAL TRANSDUCTION; SLC2A3 GENE; SLIT3 GENE; STAT3 GENE; TISSUE SPECIFICITY; ANIMAL; ARTIFICIAL NEURAL NETWORK; BAYES THEOREM; BIOLOGY; CASE CONTROL STUDY; COMPUTER SIMULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE LOCUS; GENETIC DATABASE; GENETIC PREDISPOSITION; GENETICS; MOUSE; PHENOTYPE; PROCEDURES; PROTEIN PROTEIN INTERACTION;

ANIMALS; BAYES THEOREM; CASE-CONTROL STUDIES; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; CORONARY ARTERY DISEASE; DATABASES, GENETIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HUMANS; LUMICAN; MICE; NEURAL NETWORKS (COMPUTER); PHENOTYPE; PROTEIN INTERACTION MAPS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 84960439905     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.115.306725     Document Type: Article

References (56)

1. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB, Prediction of coronary heart disease using risk factor categories. Circulation 1998 97 1837 1847
2. Berry JD, Dyer A, Cai X, Garside DB, Ning H, Thomas A, Greenland P, Van Horn L, Tracy RP, Lloyd-Jones DM, Lifetime risks of cardiovascular disease. N Engl J Med 2012 366 321 329. doi: 10.1056/NEJMoa1012848
3. Roberts R, Stewart AF, The genetics of coronary artery disease. Curr Opin Cardiol 2012 27 221 227. doi: 10.1097/HCO.0b013e3283515b4b
4. Roberts R, Genetics of coronary artery disease. Circ Res 2014 114 1890 1903. doi: 10.1161/CIRCRESAHA.114.302692
5. Deloukas P, Kanoni S, Willenborg C, Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet 2013 45 25 U52
6. Björkegren JL, Kovacic JC, Dudley JT, Schadt EE, Genome-wide significant loci: how important are they? Systems genetics to understand heritability of coronary artery disease and other common complex disorders. J Am Coll Cardiol 2015 65 830 845. doi: 10.1016/j.jacc.2014.12.033
7. Nikpay M, Goel A, Won HH, CARDIoGRAMplusC4D Consortium A comprehensive 1,000 Genomes-based genome-wide association meta-Analysis of coronary artery disease. Nat Genet 2015 47 1121 1130. doi: 10.1038/ng.3396
8. Mäkinen VP, Civelek M, Meng Q, Coronary ARtery DIsease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) Consortium Integrative genomics reveals novel molecular pathways and gene networks for coronary artery disease. PLoS Genet 2014 10 e1004502. doi: 10.1371/journal.pgen.1004502
9. Chan KH, Huang YT, Meng Q, Wu C, Reiner A, Sobel EM, Tinker L, Lusis AJ, Yang X, Liu S, Shared molecular pathways and gene networks for cardiovascular disease and type 2 diabetes mellitus in women across diverse ethnicities. Circ Cardiovasc Genet 2014 7 911 919. doi: 10.1161/CIRCGENETICS.114.000676
10. Nelson CP, Schunkert H, Samani NJ, Erridge C, Genetic analysis of leukocyte type-I interferon production and risk of coronary artery disease. Arterioscler Thromb Vasc Biol 2015 35 1456 1462. doi: 10.1161/ATVBAHA.114.304925
11. Yao C, Chen BH, Joehanes R, Integromic analysis of genetic variation and gene expression identifies networks for cardiovascular disease phenotypes. Circulation 2015 131 536 549. doi: 10.1161/CIRCULATIONAHA.114.010696
12. Lee I, Blom UM, Wang PI, Shim JE, Marcotte EM, Prioritizing candidate disease genes by network-based boosting of genome-wide association data. Genome Res 2011 21 1109 1121. doi: 10.1101/gr.118992.110
13. Schnabel RB, Baccarelli A, Lin H, Ellinor PT, Benjamin EJ, Next steps in cardiovascular disease genomic research-sequencing, epigenetics, and transcriptomics. Clin Chem 2012 58 113 126. doi: 10.1373/clinchem.2011.170423
14. Zhang B, Gaiteri C, Bodea LG, Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell 2013 153 707 720. doi: 10.1016/j.cell.2013.03.030
15. Goh KI, Cusick ME, Valle D, Childs B, Vidal M, Barabási AL, The human disease network. Proc Natl Acad Sci U S A 2007 104 8685 8690. doi: 10.1073/pnas.0701361104
16. Brænne I, Civelek M, Vilne B, Leducq Consortium CAD Genomics Prediction of causal candidate genes in coronary artery disease loci. Arterioscler Thromb Vasc Biol 2015 35 2207 2217. doi: 10.1161/ATVBAHA.115.306108
17. Sazonova O, Zhao Y, Nürnberg S, Miller C, Pjanic M, Castano VG, Kim JB, Salfati EL, Kundaje AB, Bejerano G, Assimes T, Yang X, Quertermous T, Characterization of TCF21 downstream target regions identifies a transcriptional network linking multiple independent coronary artery disease loci. PLoS Genet 2015 11 e1005202. doi: 10.1371/journal.pgen.1005202
18. Smemo S, Tena JJ, Kim KH, Obesity-Associated variants within FTO form long-range functional connections with IRX3. Nature 2014 507 371 375. doi: 10.1038/nature13138
19. Eicher JD, Landowski C, Stackhouse B, Sloan A, Chen W, Jensen N, Lien JP, Leslie R, Johnson AD, GRASP v2.0: an update on the Genome-Wide Repository of Associations between SNPs and phenotypes. Nucleic Acids Res 2015 43 Database issue D799 D804. doi: 10.1093/nar/gku1202
20. Foroughi Asl H, Talukdar HA, Kindt AS, CARDIoGRAM Consortium Expression quantitative trait Loci acting across multiple tissues are enriched in inherited risk for coronary artery disease. Circ Cardiovasc Genet 2015 8 305 315. doi: 10.1161/CIRCGENETICS.114.000640
21. Zhong H, Beaulaurier J, Lum PY, Liver and adipose expression associated SNPs are enriched for association to type 2 diabetes. PLoS Genet 2010 6 e1000932. doi: 10.1371/journal.pgen.1000932
22. Rotival M, Zeller T, Wild PS, Cardiogenics Consortium Integrating genome-wide genetic variations and monocyte expression data reveals trans-regulated gene modules in humans. PLoS Genet 2011 7 e1002367. doi: 10.1371/journal.pgen.1002367
23. Battle A, Mostafavi S, Zhu X, Potash JB, Weissman MM, McCormick C, Haudenschild CD, Beckman KB, Shi J, Mei R, Urban AE, Montgomery SB, Levinson DF, Koller D, Characterizing the genetic basis of transcriptome diversity through RNA-sequencing of 922 individuals. Genome Res 2014 24 14 24. doi: 10.1101/gr.155192.113
24. Lappalainen T, Sammeth M, Friedländer MR, Geuvadis Consortium Transcriptome and genome sequencing uncovers functional variation in humans. Nature 2013 501 506 511. doi: 10.1038/nature12531
25. Erbilgin A, Civelek M, Romanoski CE, Pan C, Hagopian R, Berliner JA, Lusis AJ, Identification of CAD candidate genes in GWAS loci and their expression in vascular cells. J Lipid Res 2013 54 1894 1905. doi: 10.1194/jlr.M037085
26. Wang IM, Zhang B, Yang X, Systems analysis of eleven rodent disease models reveals an inflammatome signature and key drivers. Mol Syst Biol 2012 8 594. doi: 10.1038/msb.2012.24
27. Yang X, Zhang B, Molony C, Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver. Genome Res 2010 20 1020 1036. doi: 10.1101/gr.103341.109
28. Zhu J, Zhang B, Smith EN, Drees B, Brem RB, Kruglyak L, Bumgarner RE, Schadt EE, Integrating large-scale functional genomic data to dissect the complexity of yeast regulatory networks. Nat Genet 2008 40 854 861. doi: 10.1038/ng.167
29. Liu H, Liu W, Liao Y, Cheng L, Liu Q, Ren X, Shi L, Tu X, Wang QK, Guo AY, CADgene: a comprehensive database for coronary artery disease genes. Nucleic Acids Res 2011 39 Database issue D991 D996. doi: 10.1093/nar/gkq1106
30. Griffith M, Griffith OL, Coffman AC, DGIdb: mining the druggable genome. Nat Methods 2013 10 1209 1210. doi: 10.1038/nmeth.2689
31. Sainio A, Järveläinen H, Extracellular matrix macromolecules: potential tools and targets in cancer gene therapy. Mol Cell Ther 2014 2 14. doi: 10.1186/2052-8426-2-14
32. Ghosh S, Vivar J, Nelson CP, Systems genetics analysis of genome-wide association study reveals novel associations between key biological processes and coronary artery disease. Arterioscler Thromb Vasc Biol 2015 35 1712 1722. doi: 10.1161/ATVBAHA.115.305513
33. Bromberg Y, Chapter 15: Disease gene prioritization. Plos Comput Biol 2013 9. doi: 10.1371/journal.pcbi.1002902
34. Kuo DS, Labelle-Dumais C, Gould DB, COL4A1 and COL4A2 mutations and disease: insights into pathogenic mechanisms and potential therapeutic targets. Hum Mol Genet 2012 21 R1 R97 110. doi: 10.1093/hmg/dds346
35. Konstandin MH, Toko H, Gastelum GM, Quijada P, De La Torre A, Quintana M, Collins B, Din S, Avitabile D, Völkers M, Gude N, Fässler R, Sussman MA, Fibronectin is essential for reparative cardiac progenitor cell response after myocardial infarction. Circ Res 2013 113 115 125. doi: 10.1161/CIRCRESAHA.113.301152
36. Kelloniemi A, Szabo Z, Serpi R, Näpänkangas J, Ohukainen P, Tenhunen O, Kaikkonen L, Koivisto E, Bagyura Z, Kerkelä R, Leosdottir M, Hedner T, Melander O, Ruskoaho H, Rysä J, The early-onset myocardial infarction associated PHACTR1 gene regulates skeletal and cardiac alpha-Actin gene expression. PLoS One 2015 10 e0130502. doi: 10.1371/journal.pone.0130502
37. Lin HJ, Kung YJ, Lin YJ, Sheu JJ, Chen BH, Lan YC, Lai CH, Hsu YA, Wan L, Tsai FJ, Association of the lumican gene functional 3'-UTR polymorphism with high myopia. Invest Ophthalmol Vis Sci 2010 51 96 102. doi: 10.1167/iovs.09-3612
38. Chakravarti S, Magnuson T, Lass JH, Jepsen KJ, LaMantia C, Carroll H, Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican. J Cell Biol 1998 141 1277 1286
39. Mienaltowski MJ, Birk DE, Mouse models in tendon and ligament research. Adv Exp Med Biol 2014 802 201 230. doi: 10.1007/978-94-007-7893-1-13
40. Fassot C, Briet M, Rostagno P, Barbry P, Perret C, Laude D, Boutouyrie P, Bozec E, Bruneval P, Latremouille C, Laurent S, Accelerated arterial stiffening and gene expression profile of the aorta in patients with coronary artery disease. J Hypertens 2008 26 747 757. doi: 10.1097/HJH.0b013e3282f4b3d0
41. Van Gaal LF, Mertens IL, De Block CE, Mechanisms linking obesity with cardiovascular disease. Nature 2006 444 875 880. doi: 10.1038/nature05487
42. Wong TC, Piehler K, Meier CG, Testa SM, Klock AM, Aneizi AA, Shakesprere J, Kellman P, Shroff SG, Schwartzman DS, Mulukutla SR, Simon MA, Schelbert EB, Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-Term mortality. Circulation 2012 126 1206 1216. doi: 10.1161/CIRCULATIONAHA.111.089409
43. Rettberg JR, Yao J, Brinton RD, Estrogen: a master regulator of bioenergetic systems in the brain and body. Front Neuroendocrinol 2014 35 8 30. doi: 10.1016/j.yfrne.2013.08.001
44. Barnabas O, Wang H, Gao XM, Role of estrogen in angiogenesis in cardiovascular diseases. J Geriatr Cardiol 2013 10 377 382. doi: 10.3969/j.issn.1671-5411.2013.04.008
45. Libby P, Ridker PM, Maseri A, Inflammation and atherosclerosis. Circulation 2002 105 1135 1143
46. Won HH, Natarajan P, Dobbyn A, Jordan DM, Roussos P, Lage K, Raychaudhuri S, Stahl E, Do R, Disproportionate Contributions of Select Genomic Compartments and Cell Types to Genetic Risk for Coronary Artery Disease. PLoS Genet 2015 11 e1005622. doi: 10.1371/journal.pgen.1005622
47. Jun JI, Lau LF, Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets. Nat Rev Drug Discov 2011 10 945 963. doi: 10.1038/nrd3599
48. Bonnans C, Chou J, Werb Z, Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol 2014 15 786 801. doi: 10.1038/nrm3904
49. Järveläinen H, Sainio A, Koulu M, Wight TN, Penttinen R, Extracellular matrix molecules: potential targets in pharmacotherapy. Pharmacol Rev 2009 61 198 223. doi: 10.1124/pr.109.001289
50. Rawlings JS, Rosler KM, Harrison DA, The JAK/STAT signaling pathway. J Cell Sci 2004 117 Pt 8 1281 1283. doi: 10.1242/jcs.00963
51. Mascareno E, El-Shafei M, Maulik N, Sato M, Guo Y, Das DK, Siddiqui MA, JAK/STAT signaling is associated with cardiac dysfunction during ischemia and reperfusion. Circulation 2001 104 325 329
52. O'Shea JJ, Plenge R, JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity 2012 36 542 550. doi: 10.1016/j.immuni.2012.03.014
53. Godoy P, Cadenas C, Hellwig B, Marchan R, Stewart J, Reif R, Lohr M, Gehrmann M, Rahnenführer J, Schmidt M, Hengstler JG, Interferon-inducible guanylate binding protein (GBP2) is associated with better prognosis in breast cancer and indicates an efficient T cell response. Breast Cancer 2014 21 491 499. doi: 10.1007/s12282-012-0404-8
54. Huan TX, Zhang B, Wang Z, Coronary ARteryDIsease Genome wide Replication and Meta-Analysis (CARDIoGRAM) Consortium, International Consortium for Blood Pressure GWAS (ICBP) A systems biology framework identifies molecular underpinnings of coronary heart disease. Arterioscl Throm Vas 2013 33 1427 1434. doi: 10.1161/ATVBAHA.112.300112
55. Lek M, Karczewski K, Minikel E, Analysis of protein-coding genetic variation in 60,706 humans [published online ahead of print October 30, 2015]. bioRxiv. doi: http://dx.doi.org/10.1101/030338. http://biorxiv.org/content/early/2015/10/30/030338
56. Marcotte R, Sayad A, Brown KR, Sanchez-Garcia F, Reimand J, Haider M, Virtanen C, Bradner JE, Bader GD, Mills GB, Pe'er D, Moffat J, Neel BG, Functional genomic landscape of human breast cancer drivers, vulnerabilities, and resistance. Cell 2016 164 293 309. doi: 10.1016/j.cell.2015.11.062